ResearchCLINICALTRIALSToday
Trial Completed: Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-inflammatory Rare and Non-rare Diseases (NCT04353609)
Researchers completed a large study of 13,770 patients with chronic inflammatory diseases (like rheumatoid arthritis and other autoimmune conditions) to understand how COVID-19 affected them. The study, led by a hospital in France, was designed to track whether patients taking medications for their autoimmune diseases had worse outcomes if they caught COVID-19. This trial has now finished collecting data.
WHY IT MATTERSIf you have an autoimmune or inflammatory disease, this completed trial provides real-world evidence about COVID-19 risk in your population—information that can help you and your doctor make informed decisions about infection prevention and disease management.